Expert Consensus and Clinical Pathway Recommendations for Transthyretin Amyloid Cardiomyopathy in Malaysia.

Authors

Mohd Rahal Yusoff, Raja Ezman Farid Raja Shariff, Choon Keong Tee, Kee Wei Lee, Nor Hanim Mohd Amin, Lean Seng Chen, Thurston Erng, Kavita Arumugam, Siti Nooraein Yaser, Jerome Tsen Chuen Tan, Suhashini Ganapaty, Roslina Omar, Thuhairah Abdul Rahman, Lock Hock Ngu, Soon Chai Low, Nur Shafini Che Rahim, Yen Yee Oon

Published in

International journal of heart failure. Volume 8. Issue 3. Pages 193-206. Epub Jul 22, 2026.

Abstract

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that remains under-recognised in Malaysia. Although disease-modifying therapies are available, their high cost and limited accessibility contribute to delays in diagnosis, compounded by gaps in clinical awareness, differences in diagnostic tool availability and disparities in healthcare resources. While international guidelines offer a comprehensive framework for diagnosing and managing ATTR-CM, local adaptation is essential to ensure their relevance and feasibility within the Malaysian healthcare system. This expert consensus provides practical, locally relevant recommendations to assist Malaysian clinicians in the timely identification and management of ATTR-CM. A multidisciplinary panel of clinicians from cardiology, haematology, nuclear medicine and other related specialties convened to develop tailored recommendations for national practice, drawing on international guidance, current evidence and local clinical practices. The guidance outlines key clinical features to raise early suspicion, proposes a diagnostic algorithm adaptable to different levels of care and offers recommendations on appropriate use of diagnostic tests-including imaging, laboratory investigations, tissue biopsy, and genetic testing when indicated-while emphasising the distinction between ATTR-CM and amyloid light chain amyloidosis, optimising non-invasive diagnostic approaches and fostering multidisciplinary collaboration across the care continuum. These consensus recommendations aim to enhance diagnostic accuracy, reduce variability in clinical practice and support earlier identification of ATTR-CM. By bridging global standards with local healthcare practices, this guidance equips clinicians to deliver timely, effective care for an underdiagnosed and often overlooked condition.

PMID:
42568427
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.